Diclofenac sodium 3 % Topical Gel
RxNorm 855642
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 855642 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: diclofenac sodium 3 % Topical Gel.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Diclofenac sodium 0.03 mg/MG Topical Gel
(Atom ID: 12330763)
PSNPrescribable
Prescribable Name (PSN):
Diclofenac sodium 3 % Topical Gel
(Atom ID: 6381132)
SYPrescribable
Synonym (SY):
Diclofenac sodium 3 % Topical Gel
(Atom ID: 3293183)
PTPrescribable
Designated preferred name (PT):
Diclofenac sodium 30 mg/g cutaneous gel
(Atom ID: 10297212)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely diclofenac sodium 30 mg/1 gram conventional release cutaneous gel (clinical drug)
(Atom ID: 10311393)
Patient Education
Diclofenac Topical (actinic keratosis)
Diclofenac topical gel (Solaraze) is used to treat actinic keratosis (flat, scaly growths on the skin caused by too much sun exposure). Diclofenac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). The way diclofenac gel works to treat actinic keratosis is not known. Diclofenac is also available as a liquid (Pennsaid) and a gel (Voltaren) that are applied to the skin to treat arthritis pain. This monograph only gives information about diclofenac gel (Solaraze) for actinic keratosis. If you are using either of the products for osteoarthritis, read the monograph entitled diclofenac topical (osteoarthritis pain).
[Learn More]
* Please review the disclaimer below.